Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid

J Neurovirol. 2003 Feb;9(1):129-35. doi: 10.1080/13550280390173300.

Abstract

Neurological complications caused by varicella-zoster virus (VZV) were diagnosed in 13 human immunodeficiency virus (HIV)-infected patients in our hospital. There was a favorable influence of highly active antiretroviral therapy (HAART) in the prevalence of these disorders among acquired immunodeficiency syndrome (AIDS) patients: Since 1996, only 1 of 961 AIDS patients had VZV neurological disease, compared to 9 of 1088 patients before that year (P =.02). Polymerase chain reaction (PCR) detected VZV DNA in cerebrospinal from 4 of 5 patients with VZV neurological disease, and from 2 of 130 HIV-infected patients with other neurological diseases (sensitivity 0.8, specificity 0.98 [95% confidence intervals 0.45-1 and 0.96-1, respectively], positive predictive value 0.94).

MeSH terms

  • Adolescent
  • Adult
  • Antiretroviral Therapy, Highly Active
  • DNA, Viral / analysis
  • DNA, Viral / cerebrospinal fluid
  • Encephalitis, Varicella Zoster / cerebrospinal fluid
  • Encephalitis, Varicella Zoster / diagnosis*
  • Encephalitis, Varicella Zoster / epidemiology*
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Herpesvirus 3, Human / genetics*
  • Herpesvirus 3, Human / isolation & purification
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Prevalence

Substances

  • DNA, Viral